Regend Overview
- Year Founded
-
2015
- Status
-
Private
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$50.3M
- Investors
-
12
Regend General Information
Description
Developer of stem cell therapy products and regenerative medicine intended for medical institutions, clinical research organizations, and therapeutic developers. The company is mainly engaged in research and development of regenerative medicine, providing users with interstitial lung disease, assisted reproduction, stem cell storage, and chronic obstructive pulmonary disease treatment solutions.
Contact Information
Website
www.regend.cnCorporate Office
- A2-411
- Number 218 Xinghu Street
- Suzhou, Jiangsu 215123
- China
Corporate Office
- A2-411
- Number 218 Xinghu Street
- Suzhou, Jiangsu 215123
- China
Regend Timeline
Regend Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series C) | 11-Feb-2026 | $50.3M | Completed | Generating Revenue | ||
| 9. Later Stage VC | 03-Mar-2025 | Completed | Generating Revenue | |||
| 8. Secondary Transaction - Private | 03-Mar-2025 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B1) | 09-Feb-2025 | Completed | Generating Revenue | |||
| 6. Secondary Transaction - Private | 23-Mar-2023 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 01-Jan-2022 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A1) | 01-May-2021 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 01-Jul-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 01-Feb-2017 | $3.22M | Completed | Generating Revenue | ||
| 1. Seed Round | 01-Aug-2015 | $3.22M | $3.22M | Completed | Startup |
Regend Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Hefei Hi-Tech VC | Venture Capital | Minority | ||
| Hefei Industry Investment Group | Venture Capital | Minority | ||
| Hongtai Capital Holdings | Venture Capital | Minority | ||
| Tasly Capital | Corporate Venture Capital | Minority | ||
| Yuze Investment Management | Venture Capital | Minority |
Regend FAQs
-
When was Regend founded?
Regend was founded in 2015.
-
Where is Regend headquartered?
Regend is headquartered in Suzhou, China.
-
What industry is Regend in?
Regend’s primary industry is Drug Discovery.
-
Is Regend a private or public company?
Regend is a Private company.
-
What is Regend’s current revenue?
The current revenue for Regend is .
-
How much funding has Regend raised over time?
Regend has raised $69.2M.
-
Who are Regend’s investors?
Hefei Hi-Tech VC, Hefei Industry Investment Group, Hongtai Capital Holdings, Tasly Capital, and Yuze Investment Management are 5 of 12 investors who have invested in Regend.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process